FROM BIOMARKERS TO DIAGNOSIS: TRANSFORMING DEMENTIA CARE

Name: FROM BIOMARKERS TO DIAGNOSIS: TRANSFORMING DEMENTIA CARE
Start: 2027-03-18T09:10
End: 2027-03-18T11:10
Location: Centre de Convencions Internacional de Barcelona

AD/PD 2027 – Advances in Science & Therapy · 18 March 2027 · 09:10–11:10 · Hall 117

FROM BIOMARKERS TO DIAGNOSIS: TRANSFORMING DEMENTIA CARE was a session at AD/PD 2027 – Advances in Science & Therapy on 18 March 2027 in Barcelona, with 8 speakers on record.

Speakers

Oskar Hansson — Speaker Eli Lilly and Company
Charlotte Teunissen — Speaker Amsterdam UMC
Cristina Sánchez-Martín — Speaker Reina Sofia Foundation Alzheimer Centre, CIEN Foundation, ISCIII
Sarah Fullam — Speaker
Agneta Nordberg — Speaker Karolinska institutet
Bin Xu — Speaker North Carolina Central University & Duke-UNC Alzheimer's Disease Research Center
Takeshi Iwatsubo — Speaker National Center of Neurology and Psychiatry
Michelle M. Mielke — Moderator Wake Forest University School of Medicine